We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Neue Therapiemöglichkeiten der Alopecia areata

    Alopecia areata has a lifetime prevalence of 2% and is thereby one of the most common autoimmune diseases. It affects patients at every age. Recent...

    Johannes Griss in hautnah
    Article Open access 15 April 2023
  2. Association Between Natural Hair Color, Race, and Alopecia

    Introduction

    Limited epidemiologic data has suggested direct associations between hair pigment, race, and incidence of alopecia areata (AA). Here, we...

    Kanika Kamal, David **ang, ... Nicholas Theodosakis in Dermatology and Therapy
    Article Open access 02 July 2024
  3. Taste disorders and alopecia in myasthenia gravis

    Background

    Non-motor symptoms in myasthenia gravis (MG) are rarely confirmed. Although there are some small cohort studies, a large-systemic survey...

    Akiyuki Uzawa, Shigeaki Suzuki, ... Kimiaki Utsugisawa in BMC Neurology
    Article Open access 25 April 2024
  4. Baricitinib: A Review in Severe Alopecia Areata

    Baricitinib (Olumiant ® ), a Janus kinase (JAK) inhibitor, is the first drug approved for the treatment of severe alopecia areata in the USA and the...

    Simon Fung, Matt Shirley in American Journal of Clinical Dermatology
    Article 16 June 2023
  5. Central centrifugal cicatricial alopecia: a deeper insight into the disease

    Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia of multifactorial etiology that presents on the vertex as patchy areas of hair...

    Syeda Zainab Fatima in Wiener Medizinische Wochenschrift
    Article 21 February 2024
  6. Alopecia Areata: Current Treatments and New Directions

    Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at the hair follicle level....

    Dante Dahabreh, Seungyeon Jung, ... Emma Guttman-Yassky in American Journal of Clinical Dermatology
    Article 22 August 2023
  7. Lasers in the management of alopecia: a review of established therapies and advances in treatment

    Alopecia, also known as hair loss, is a highly prevalent condition affecting millions of men and women in the United States and worldwide, making it...

    Philippe Jean-Pierre, Anika Pulumati, ... Keyvan Nouri in Lasers in Medical Science
    Article Open access 17 April 2024
  8. Androgenetic Alopecia: Therapy Update

    Androgenetic alopecia (AGA), also known as male pattern hair loss (MPHL) or female pattern hair loss (FPHL), is the most common form of alopecia...

    Shivali Devjani, Ogechi Ezemma, ... Maryanne Senna in Drugs
    Article 11 May 2023
  9. Treatment Options for Alopecia Areata in Children and Adolescents

    Alopecia areata (AA) lifetime incidence is around 2%, with many patients first experiencing symptoms during childhood. However, ritlecitinib is the...

    Linnea L. Westerkam, Diana B. McShane, ... Dean S. Morrell in Pediatric Drugs
    Article 11 March 2024
  10. Research trends in alopecia areata: a cross-sectional bibliometric analysis of the top cited studies

    In the field of alopecia areata research, various focuses including risk factors, epidemiology, molecular pathways, and treatment were constantly...

    Hui-Chin Chang, Tsu-Man Chiu, ... Shuo-Yan Gau in Archives of Dermatological Research
    Article 25 May 2024
  11. Alopecia associated with dimethyl fumarate treatment for multiple sclerosis

    After 2 weeks of treatment, a woman with multiple sclerosis treated with dimethyl fumarate developed alopecia. Considering the adverse events, the...

    Ana Abičić, Ivan Adamec, Mario Habek in Wiener Medizinische Wochenschrift
    Article 15 March 2023
  12. Verhaltens- und Hypnotherapie bei Alopecia areata: Eine Einzelfallstudie

    Background

    Alopecia areata (AA) is a form of hair loss with bald circular areas on the head triggered by auto- and/or psychoneuroimmunological...

    Alois Kogler, Ilse Müller, ... Uwe Gieler in Psychotherapie Forum
    Article Open access 17 May 2024
  13. Refractory alopecia in lupus treated with tofacitinib — a case-based review

    One of the common cutaneous symptoms of systemic lupus erythematosus (SLE) that may have major psychosocial effects in a female is diffuse alopecia....

    Rajdeep Sarkar, Prakashini MV, ... Sakir Ahmed in Clinical Rheumatology
    Article 15 May 2023
  14. The role of laser and energy-assisted drug delivery in the treatment of alopecia

    It has been recently established that laser treatment can be combined with topical or intralesional medications to enhance the delivery of drugs and...

    Eliza Balazic, Ahava Muskat, ... Kseniya Kobets in Lasers in Medical Science
    Article Open access 21 February 2024
  15. Estimation of health utility values for alopecia areata

    Purpose

    Alopecia areata (AA) is an autoimmune-mediated inflammatory dermatological disease characterised by non-scarring hair loss affecting the scalp...

    Daniel Aggio, Caleb Dixon, ... Andrew Lloyd in Quality of Life Research
    Article Open access 29 March 2024
  16. Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients

    Purpose

    Dermatologic adverse events commonly result in the interruption of oncologic treatment, and targeted therapies are the most frequently...

    Abena Minta, Lucy Rose, ... Brittany Dulmage in Supportive Care in Cancer
    Article 22 November 2023
  17. The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016

    Introduction

    Alopecia areata (AA) is an autoimmune skin disease presenting as nonscarring hair loss. Information on the epidemiology of AA, especially...

    Sissel Brandt Toft Sørensen, Prethibha George, ... Vera Ehrenstein in Dermatology and Therapy
    Article Open access 16 April 2024
  18. Reduced rates of substance use disorder in patients with alopecia: An all of us case-control study

    Alopecia areata (AA), depression, anxiety, and decreased quality of life are highly associated in the literature. It has been noted that there is an...

    Hailey Konisky, Peter Y. Ch’en, Kseniya Kobets in Archives of Dermatological Research
    Article 01 June 2024
  19. The development of non-scarring alopecia in women who wear the hijab

    Little is known about hair loss associated with wearing the hijab, a religious head covering worn by Muslim women. We performed a single-center...

    Marissa S. Ceresnie, Lindsey Mohney, ... Tasneem F. Mohammad in Archives of Dermatological Research
    Article 23 August 2023
  20. Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies

    Frontal fibrosing alopecia (FFA) represents a distinctive form of primary lymphocytic scarring alopecia characterized by fronto-temporal hair...

    Michela Starace, Stephano Cedirian, ... Bianca M. Piraccini in Dermatology and Therapy
    Article Open access 31 May 2024
Did you find what you were looking for? Share feedback.